v3.25.2
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Retained earnings
Treasury stock
Accumulated other comprehensive (loss) income
Total
Balance, beginning of period at Dec. 31, 2023 $ 100,426 $ 191,108 $ (27,367) $ (2,737) $ 261,430
Balance, beginning of period (in shares) at Dec. 31, 2023 10,063        
Increase (Decrease) in Stockholders' Equity          
Net income   9,586     9,586
Other comprehensive income (loss), net of tax       (115) (115)
Dividends on common stock $ 53 (1,314)     (1,261)
Dividends on common stock (in shares) 2        
Share-based compensation [1] $ 1,197       1,197
Share-based compensation (in shares) [1] 129        
Treasury stock purchased, at cost     (4,076)   (4,076)
Treasury stock purchased, at cost (in shares) (150)        
Balance, end of period at Mar. 31, 2024 $ 101,676 199,380 (31,443) (2,852) 266,761
Balance, end of period (in shares) at Mar. 31, 2024 10,044        
Balance, beginning of period at Dec. 31, 2023 $ 100,426 191,108 (27,367) (2,737) 261,430
Balance, beginning of period (in shares) at Dec. 31, 2023 10,063        
Increase (Decrease) in Stockholders' Equity          
Net income         19,040
Other comprehensive income (loss), net of tax       (343) (343)
Balance, end of period at Jun. 30, 2024 $ 102,226 207,534 (33,285) (3,080) 273,395
Balance, end of period (in shares) at Jun. 30, 2024 9,975        
Balance, beginning of period at Mar. 31, 2024 $ 101,676 199,380 (31,443) (2,852) 266,761
Balance, beginning of period (in shares) at Mar. 31, 2024 10,044        
Increase (Decrease) in Stockholders' Equity          
Net income   9,454     9,454
Other comprehensive income (loss), net of tax       (228) (228)
Dividends on common stock $ 52 (1,300)     (1,248)
Dividends on common stock (in shares) 2        
Share-based compensation $ 498       498
Share-based compensation (in shares) (2)        
Treasury stock purchased, at cost     (1,842)   (1,842)
Treasury stock purchased, at cost (in shares) (69)        
Balance, end of period at Jun. 30, 2024 $ 102,226 207,534 (33,285) (3,080) 273,395
Balance, end of period (in shares) at Jun. 30, 2024 9,975        
Balance, beginning of period at Dec. 31, 2024 $ 103,936 227,331 (33,577) (2,107) $ 295,583
Balance, beginning of period (in shares) at Dec. 31, 2024 10,026       10,026
Increase (Decrease) in Stockholders' Equity          
Net income   11,598     $ 11,598
Other comprehensive income (loss), net of tax       275 275
Dividends on common stock $ 56 (1,411)     (1,355)
Dividends on common stock (in shares) 1        
Share-based compensation [1] $ 41       41
Share-based compensation (in shares) [1] 49        
Balance, end of period at Mar. 31, 2025 $ 104,033 237,518 (33,577) (1,832) 306,142
Balance, end of period (in shares) at Mar. 31, 2025 10,076        
Balance, beginning of period at Dec. 31, 2024 $ 103,936 227,331 (33,577) (2,107) $ 295,583
Balance, beginning of period (in shares) at Dec. 31, 2024 10,026       10,026
Increase (Decrease) in Stockholders' Equity          
Net income         $ 28,089
Other comprehensive income (loss), net of tax       182 182
Balance, end of period at Jun. 30, 2025 $ 104,674 252,606 (35,515) (1,925) $ 319,840
Balance, end of period (in shares) at Jun. 30, 2025 10,032       10,032
Balance, beginning of period at Mar. 31, 2025 $ 104,033 237,518 (33,577) (1,832) $ 306,142
Balance, beginning of period (in shares) at Mar. 31, 2025 10,076        
Increase (Decrease) in Stockholders' Equity          
Net income   16,491     16,491
Other comprehensive income (loss), net of tax       (93) (93)
Dividends on common stock $ 53 (1,403)     (1,350)
Dividends on common stock (in shares) 1        
Share-based compensation $ 588       588
Share-based compensation (in shares) 5        
Treasury stock purchased, at cost     (1,938)   (1,938)
Treasury stock purchased, at cost (in shares) (50)        
Balance, end of period at Jun. 30, 2025 $ 104,674 $ 252,606 $ (35,515) $ (1,925) $ 319,840
Balance, end of period (in shares) at Jun. 30, 2025 10,032       10,032
[1] Includes the issuance of common stock under employee benefit plans, which includes nonqualified stock options and restricted stock expense related entries, employee option exercises and the tax benefit of options exercised.